Insider filing · NBIX
Jude Onyia
Chief Scientific Officer
profile →
Neurocrine Biosciences, Inc.
NBIX · Healthcare · 59 filings in 24 months
ticker →
Jude Onyia sold $1.7M of Neurocrine Biosciences (NBIX)
Executed May 27, disclosed May 29, 2 days later.
Value, as filed
$1.7M
11,000 sh × $155.53
Executed
May 27
the trade date, as filed
Disclosed
May 29
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JOJude Onyia (Chief Scientific Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $1.8M of NBIX (11,000 sh × $160.25, as filed), executed Jun 1.
The name
NBIXHealthcare · Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunolog…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jude Onyia in NBIX
NBIXSALE
Neurocrine Biosciences, Inc.
$1.8M11,000 sh × $160.25
Exec Jun 1
Filed Jun 2 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $7.8M
59,819 sh × $130.46
Exec Jul 9 2025
Filed Jul 11 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $2.6M
20,362 sh × $130.13
Exec Jul 2 2025
Filed Jul 7 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $336K
2,879 sh across 2 lots
Exec Feb 13 2025
Filed Feb 14 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $294K
2,331 sh × $126.29
Exec Nov 29 2024
Filed Dec 3 2024 · 5:30 PM ET